Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 3 minute read Pharma Industry News Biogen to acquire Nightstar Therapeutics in a deal worth $800m to target retinal diseases In a significant move within the biotech sector, Biogen, the US-based biotechnology giant, has announced its agreement to… bypharmanewsdailyMarch 31, 2019